Switchback Medical: Strategic Investment Raised From TJC

By Amit Chowdhry • Oct 7, 2025

Switchback Medical recently announced a significant strategic investment from an affiliate of TJC, L.P. TJC is a well-established private investment firm known for its collaborative approach in supporting businesses. This investment marks a major step for Switchback Medical as it merges with its affiliates, LightningCath, and Proto Lase, creating a unified platform for growth and innovation. Despite this integration, the founders and existing shareholders of all three businesses will maintain significant ownership in the newly formed company.

Switchback Medical is dedicated to the design, development, and manufacturing of highly precise catheters, advanced delivery systems, and essential components tailored for innovative, minimally invasive medical devices. This specialization positions Switchback as a critical partner in the medical technology sector, catering to the increasing demand for advanced healthcare solutions.

TJC has about $33.2 billion in assets under management. And with over 40 years of experience, TJC has consistently invested in businesses alongside CEOs, entrepreneurs, and founders. The firm adopts a partnership-driven approach, which involves acquiring or investing in companies while working closely with their management teams to help elevate their growth trajectories.

At the helm of Switchback is Co-Founder and CEO Brady Hatcher, who has extensive experience in the MedTech contract development and manufacturing organization (CDMO) space. Hatcher is well-regarded for his robust industry relationships and a successful record of driving business growth. Under his leadership, Switchback’s management team has been integral to the Company’s achievements so far and is well-equipped to steer the organization toward continued scalability.

Advisors/counsel: Ernst & Young Capital Advisors is acting as exclusive financial advisor and Winthrop & Weinstine is serving as legal counsel to Switchback. Moelis & Company is acting as financial advisor and McDermott Will & Schulte is serving as legal counsel to TJC.

KEY QUOTES:

“We’re thrilled to partner with the TJC team, which has great cultural alignment with our organization and shares our vision for Switchback’s next phase of growth. Their investment will be instrumental in supporting us as we continue to scale and serve our customers.”

Switchback CEO Brady Hatcher

“Switchback’s culture of innovation, well-regarded engineering expertise, and deep customer partnerships have fueled its success, and we’re excited to help drive its next chapter of growth.”

Dan Williams, Partner and Head of Healthcare at TJC